Delivery Order SPE2DB20D3101-SPE2DB25FRRM6
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,916.80 on July 31, 2025, for the supply of Enoxaparin 300 mg/3 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and performance will be executed from the awardee's facility in Conshohocken, Pennsylvania. Enoxaparin is a low-molecular-weight heparin used for anticoagulation therapy in military and federal healthcare settings. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,215,870 units of the drug Enoxaparin 40 mg/0.4 ml syringe. The contract has a firm fixed price of $1,204.92 and an ultimate completion date of January 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- The Defense Logistics Agency awarded a $335,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg/ml enoxaparin syringes. As the prime contractor, Amerisourcebergen will deliver the anticoagulant drug to a facility in Conshohocken, Pennsylvania by July 6, 2023 in support of the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA medical product...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,602.88, is for the delivery of Enoxaparin 300 mg/3 ml vials. It is a firm fixed price delivery order contract, with a period of performance through March 3, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $322,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 80mg/0.8ml enoxaparin syringes. The single award was issued under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania over a one day period from June 27-28, 2023. No subcontractors or set aside designations...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,841.38 firm fixed price contract is for the supply of 100 mg/mL Enoxaparin syringes. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.35 firm fixed-price contract is for the delivery of 80 mg/0.8 mL syringes of the anticoagulant drug enoxaparin, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,127.11, is for the delivery of Enoxaparin 120 mg/0.8 mL syringes. This is a firm fixed-price delivery order contract with a completion date of March 17, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $97,000 to Amerisourcebergen Drug Corporation for the supply of enoxaparin sodium injection. The contract has a period of performance from July 7-10, 2023, with all products to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 80 mg/0.8 ml syringes. The contract has a ceiling value of $2,257.11 and is a firm fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...